Additionally, Luteolin, another bioactive compound in EVOO, shares structural identity with Quercetin, a plant flavonol from the flavonoid group of polyphenols, that is found in many fruits, vegetables, leaves, etc. Quercetin is currently involved in clinical trials for AD and has demonstrated NRF2 activation ability. The gene discussed is NFE2L2; the disease is Alzheimer disease.